Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.7677
-0.0433 (-5.34%)
At close: Jul 2, 2026, 4:00 PM EDT
0.8000
+0.0323 (4.21%)
After-hours: Jul 2, 2026, 7:34 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $11.63 million as of July 2, 2026. Its market cap has increased by 25.92% in one year.
Market Cap
11.63M
Enterprise Value
8.50M
1-Year Change
25.92%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $11.63M, a decrease of -97.16%. That is a compound annual growth rate of -24.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 11.63M | 28.81% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 13.18M |
| Jasper Therapeutics | 12.72M |
| Exicure | 12.62M |
| Chemomab Therapeutics | 12.24M |
| Akari Therapeutics, | 12.05M |
| Kiora Pharmaceuticals | 11.97M |
| Psyence Biomedical | 11.86M |
| CytoMed Therapeutics | 11.72M |